X

ISOPRINOSINE SYRUP 250mg/5ml

Product Information

Registration Status: Active

SIN01361P

ISOPRINOSINE SYRUP 250mg/5ml is approved to be sold in Singapore with effective from 1988-05-18. It is marketed by UNITED ITALIAN TRADING CORPORATION PTE LTD, with the registration number of SIN01361P.

This product contains Methisoprinol 250mg/5ml in the form of SYRUP. It is approved for ORAL use.

This product is manufactured by SWISS PHARMA RESEARCH LABORATORIES INC in PHILIPPINES.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...


Description

Inosine pranobex (Isoprinosine or Methisoprinol) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug.

Indication

Inosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.

Mechanism of Action

Inosine pranobex stimulates cell-mediated immune processes to viral infections.

Pharmacokinetics

Absorption
Rapidly absorbed from GIT
Distribution
Metabolism
Elimination

Toxicity

Mouse LD50 (Intravenous ): 1570 mg/kg Muse LD50 (Oral) : 9410mg/kg Mouse LD50 (subcutaneous) ; 2960mg/kg

Active Ingredient/Synonyms

IAD | Inosine acedobene dimepranol | Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3) | Inosiplex | Isoprinosine | Methisoprinol | Inosine pranobex |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!